Literature DB >> 2322137

Cognition in early human immunodeficiency virus infection.

F L Wilkie1, C Eisdorfer, R Morgan, D A Loewenstein, J Szapocznik.   

Abstract

Relatively little is known about cognitive changes in early human immunodeficiency virus (HIV) infection. This study examined cognitive functioning in 46 HIV-positive gay men relative to an age and education equivalent group of 13 HIV-negative gay men. The HIV-positive men were asymptomatic except for lymphadenopathy or T4 counts less than 700. The cognitive battery measured language, memory, visuospatial, information processing speeds, reasoning, attention, and psychomotor processes. The HIV-positive group was significantly slower in processing information and performed significantly less well than the HIV-negative group on certain verbal memory measures. Deviations of 1 as well as 2 SDs from the norm/control group mean on four or more tests were observed in 43% and 22% of the HIV-positive subjects, respectively, compared with 8% and none of the HIV-negative subjects, respectively. The results suggest that cognitive inefficiency occurs in a subsample of individuals during early HIV infection.

Entities:  

Mesh:

Year:  1990        PMID: 2322137     DOI: 10.1001/archneur.1990.00530040085022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  A multilevel modeling approach to examining individual differences in skill acquisition for a computer-based task.

Authors:  Sankaran N Nair; Sara J Czaja; Joseph Sharit
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2007-06       Impact factor: 4.077

Review 2.  Neuropsychiatric aspects of HIV infection among older adults.

Authors:  C H Hinkin; S A Castellon; J H Atkinson; K Goodkin
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

3.  Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Authors:  Karl Goodkin; Benedetto Vitiello; William D Lyman; Deshratn Asthana; J Hampton Atkinson; Peter N R Heseltine; Rebeca Molina; Wenli Zheng; Imad Khamis; Frances L Wilkie; Paul Shapshak
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

4.  Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men.

Authors:  K Goodkin; D J Feaster; R Tuttle; N T Blaney; M Kumar; M K Baum; P Shapshak; M A Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

5.  A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits.

Authors:  K Goodkin; D J Feaster; D Asthana; N T Blaney; M Kumar; T Baldewicz; R S Tuttle; K J Maher; M K Baum; P Shapshak; M A Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

6.  Factors influencing use of an e-health website in a community sample of older adults.

Authors:  Sara J Czaja; Joseph Sharit; Chin Chin Lee; Sankaran N Nair; Mario A Hernández; Neysarí Arana; Shih Hua Fu
Journal:  J Am Med Inform Assoc       Date:  2012-07-16       Impact factor: 4.497

Review 7.  Neuropsychiatric manifestations of HIV infection and AIDS.

Authors:  Benoit Dubé; Tami Benton; Dean G Cruess; Dwight L Evans
Journal:  J Psychiatry Neurosci       Date:  2005-07       Impact factor: 6.186

Review 8.  Neuropsychiatric aspects of human immunodeficiency virus (HIV) infection.

Authors:  Francisco Fernandez
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

9.  Investigating the Roles of Knowledge and Cognitive Abilities in Older Adult Information Seeking on the Web.

Authors:  Joseph Sharit; Mario A Hernández; Sara J Czaja; Peter Pirolli
Journal:  ACM Trans Comput Hum Interact       Date:  2008       Impact factor: 2.351

10.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.